Medicina, Dermatología y Toxicología
Departamento
![Foto de José Ignacio](/img/nophoto.png)
José Ignacio
Riezu Boj
Publicaciones en las que colabora con José Ignacio Riezu Boj (59)
2024
-
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial
Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781
2023
-
A Predictive Tool Based on DNA Methylation Data for Personalized Weight Loss through Different Dietary Strategies: A Pilot Study
Nutrients, Vol. 15, Núm. 24
-
Crosstalk between Gut Microbiota and Epigenetic Markers in Obesity Development: Relationship between Ruminococcus, BMI, and MACROD2/SEL1L2 Methylation
Nutrients, Vol. 15, Núm. 7
2022
-
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers
Panminerva medica, Vol. 64, Núm. 4, pp. 485-496
-
A weight-loss model based on baseline microbiota and genetic scores for selection of dietary treatments in overweight and obese population
Clinical Nutrition, Vol. 41, Núm. 8, pp. 1712-1723
-
Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity
Epigenetics, Vol. 17, Núm. 1, pp. 81-92
-
Possible metabolic interplay between quality of life and fecal microbiota in a presenior population–Preliminary results
Nutrition, Vol. 103-104
2021
-
A predictive regression model of the obesity-related inflammatory status based on gut microbiota composition
International Journal of Obesity, Vol. 45, Núm. 10, pp. 2261-2268
-
Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention
European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3279-3301
-
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study
European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057
-
Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition
Inflammation Research, Vol. 70, Núm. 1, pp. 29-49
-
Gut microbiota bacterial species associated with mediterranean diet-related food groups in a northern spanish population
Nutrients, Vol. 13, Núm. 2, pp. 1-17
-
Gut microbiota differences according to ultra-processed food consumption in a spanish population
Nutrients, Vol. 13, Núm. 8
-
Potential Mechanisms Linking Food-Derived MicroRNAs, Gut Microbiota and Intestinal Barrier Functions in the Context of Nutrition and Human Health
Frontiers in Nutrition, Vol. 8
-
Test metagenómicos y de disbiosis: presente y futuro
Revista española de nutrición humana y dietética, Vol. 25, Núm. 3, pp. 20-21
-
The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits
Scientific reports, Vol. 11, Núm. 1, pp. 21859
-
Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study
Diagnostics, Vol. 11, Núm. 6
2020
-
Association of the SH2B1 RS7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease
Nutrients, Vol. 12, Núm. 5
-
Circulating adiposity-related microRNAs as predictors of the response to a low-fat diet in subjects with obesity
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 2956-2967
-
Comprehensive analysis reveals novel interactions between circulating micrornas and gut microbiota composition in human obesity
International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-17